IRD - Opus Genetics, Inc. - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	Qty	oc	Own	H
4/27/26 16:28	4/23/26	IRD	Health	Drug	Pharmaceutical Preparations	Yerxa Benjamin R	NC	DO	P	S	-39	5.24	-7	-1	712	D
4/27/26 16:28	4/23/26	IRD	Health	Drug	Pharmaceutical Preparations	Schachle Joseph K	NC	O	COO	S	-25	5.22	-5	-2	296	D
4/27/26 16:27	4/23/26	IRD	Health	Drug	Pharmaceutical Preparations	Zaremba Rabourn Amy	NC	O	Head of	S	-9	5.20	-2	-1	189	D
4/27/26 16:27	4/23/26	IRD	Health	Drug	Pharmaceutical Preparations	Magrath George	NC	DO	CEO	S	-50	5.22	-10	-1	1,741	D
4/27/26 16:26	4/23/26	IRD	Health	Drug	Pharmaceutical Preparations	Jayagopal Ashwath	NC	O	Chief Sc	S	-39	5.19	-8	-1	509	D
4/27/26 16:26	4/23/26	IRD	Health	Drug	Pharmaceutical Preparations	Gagnon Robert E.	NC	O	CFO	S	-41	5.18	-8	-1	592	D
3/18/26 16:12	3/16/26	IRD	Health	Drug	Pharmaceutical Preparations	Schachle Joseph K	NC	O	COO	S	-20	5.25	-4	-1	301	D
3/18/26 16:11	3/16/26	IRD	Health	Drug	Pharmaceutical Preparations	Zaremba Rabourn Amy	NC	O	Head of	S	-15	5.25	-3	-1	190	D
3/18/26 16:10	3/16/26	IRD	Health	Drug	Pharmaceutical Preparations	Magrath George	NC	DO	CEO	S	-127	5.21	-24	-1	1,751	D
3/18/26 16:09	3/16/26	IRD	Health	Drug	Pharmaceutical Preparations	Jayagopal Ashwath	NC	O	Chief Sc	S	-19	5.12	-4	-1	517	D
12/11/25 17:35	12/9/25	IRD	Health	Drug	Pharmaceutical Preparations	Foundation Fighting Blindness Retinal Degeneration Fund	NC	DH	See Rema	S	-8,600	2.15	-4,000	-42	5,492	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person